University of Wyoming News · Jul 2026
Recent university coverage says Sigma Genetics is a company partner on a project to stabilize RNA-lipid nanoparticles in dry state form for transport and storage.
Sigma Genetics is a biotechnology company that is building…
Company research
Public company, workplace, funding, and market signals
Overview
Sigma Genetics is a Seattle-based biotechnology startup building Magnetoporation/Magnetoporator devices that use external pulsed magnetic fields to deliver DNA, RNA, proteins, and other charged molecules into cells. Public sources describe a very small, research-heavy team focused on translational cell-therapy, blood-product, and biomanufacturing use cases. Current sources show Zachary Rapp as CEO, while older YC/profile sources vary on founder naming, so founder/leadership attribution should be treated carefully.
Primary product
Magnetoporation / Magnetoporator device for intracellular delivery
Founded
2016
Headquarters
Seattle, Washington, United States
Team size
1-10
Industry
Biotechnology
Sub-industry
Gene delivery / cell therapy manufacturing platform
Offices
Open Positions
0 jobs at Sigma Genetics
No open positions
Check back later for new openings